Kimiyoshi Sakaguchi

Hamamatsu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

Feasibility and Efficacy of Lorlatinib in Japanese Patients With Relapsed/Refractory ALK-Aberrant Neuroblastoma.

Journal: Pediatric blood & cancer

Published: May 07, 2026

Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Combination of oral temozolomide and etoposide as palliative chemotherapy for recurrent or progressive neuroblastoma.

Journal: Pediatric hematology and oncology

Published: January 06, 2026

Functional characterization of Griscelli syndrome type 2 sine albinism in Japanese patients.

Functional characterization of Griscelli syndrome type 2 sine albinism in Japanese patients.

Journal: Journal of human immunity

Published: December 23, 2025

Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph+ Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.

Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph+ Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.

Journal: Pediatric blood & cancer

Published: August 03, 2025

Outcome of chemotherapy dose reduction in overweight Japanese children with acute lymphoblastic leukemia.

Outcome of chemotherapy dose reduction in overweight Japanese children with acute lymphoblastic leukemia.

Journal: International journal of hematology

Published: June 01, 2025

Production of 11-ketotestosterone in childhood adrenal tumors with virilization or peripheral precocious puberty: Dominant expression of 11β-hydroxysteroid dehydrogenase type 2.

Production of 11-ketotestosterone in childhood adrenal tumors with virilization or peripheral precocious puberty: Dominant expression of 11β-hydroxysteroid dehydrogenase type 2.

Journal: The Journal of steroid biochemistry and molecular biology

Published: January 12, 2025

Post-transplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21.

Post-transplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21.

Journal: Haematologica

Published: September 26, 2024

Silent inactivation of asparaginase in Japan: results of the prospective ALL-ASP19 trial.

Silent inactivation of asparaginase in Japan: results of the prospective ALL-ASP19 trial.

Journal: International journal of hematology

Published: March 04, 2024

Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group.

Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group.

Journal: International journal of hematology

Published: December 27, 2023

Utility of ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL.

Utility of ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL.

Journal: Epigenetics

Published: October 15, 2023

RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing.

RNA sequencing and target long-read sequencing reveal an intronic transposon insertion causing aberrant splicing.

Journal: Journal of human genetics

Published: August 09, 2023

Clinical features of immature leukemias in children.

Clinical features of immature leukemias in children.

Journal: International journal of hematology

Published: July 15, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026